Clinical Trial Update: Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update showing irofulven was studied in patients with stage IVB or recurrent cervical cancer and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Irofulven (irofulven)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED